Daily Briefing

An overlooked source of pollution: Inhalers?


Two studies published in JAMA have found that the inhalers millions of Americans use for asthma and other lung diseases are significant — and often overlooked — contributors to climate pollution, Jen Christensen reports for CNN. 

What the research shows

Inhalers are a lifeline for millions of Americans living with asthma and other chronic lung diseases, but they come with a hidden cost. The same propellants that help patients breathe easier also release planet-warming gasses that are thousands of times stronger than carbon dioxide (CO2).

Over the past decade, researchers have found that U.S. inhalers produced 24.9 million metric tons of CO2-equivalent emissions — about the same as half a million cars or the electricity use of 470,000 homes each year.

For the first study, William Feldman and colleagues at the University of California, Los Angeles (UCLA) and Brigham and Women's Hospital analyzed 1.6 billion inhalers dispensed in the United States from 2014 to 2024 using national pharmacy data.

Feldman and colleagues found that 98% of emissions came from metered-dose inhalers (MDIs), which use hydrofluoroalkane propellants, while dry-powder and soft-mist inhalers produced far less emissions.

Annual emissions rose 24% during the 10-year study period, mostly from common medicines such as albuterol, budesonide-formoterol, and fluticasone propionate, which together made up 87% of total emissions. The researchers estimated the social cost of that pollution at $5.7 billion.

A second analysis looked at the Department of Veterans Affairs, which since 2021 has encouraged doctors to prescribe dry-powder inhalers instead of MDIs when possible. That shift cut planet-warming gases by more than 68% between 2008 and 2023. The findings suggest that choosing a different device — rather than a different medicine — can make a big environmental difference.

Commentary

Feldman, a pulmonologist and health services researcher at UCLA, said the findings underscore how even small medical devices can have an outsized impact. "They are these tiny little products, and it's hard to imagine that they can be such contributors," he said. "[B]ut it's an eminently fixable problem with other products available and other products coming. So it feels like a kind of low-hanging fruit to address the emissions issue."

In an editorial published alongside the studies, Alexander Rabin, Jyothi Tirumalasetty, and Stephanie Maximous called inhaler reform one of "the most promising opportunities for the health sector to decarbonize" and said there is "a path to reform that need not compromise care."

Still, switching inhalers isn't a simple move for everyone. Kate Bender of the American Lung Association — who also has asthma — said, "It drives me crazy that the medication I use to address my symptoms drives climate change," and added that "as we get to that future … we need to make sure people still have access to inhalers with propellants and the other options."

Doctors say MDIs remain lifesaving for many patients, especially children who need spacers or older adults who can't inhale powder versions effectively. But experts agree the healthcare system should move toward lower-emission alternatives as more become available.

"It's really on all of us to try to do our part in reducing emissions," Feldman said.

(Christensen, CNN, 10/6)


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

RELATED RESOURCES

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece

Email ask@advisory.com to learn more

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This is for members only. Learn more.

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.